Open, randomized, comparative study of efficacy and safety between Haemopressin® and Glypressin® in treating acute esophageal varices hemorrhage

Hepato-Gastroenterology

Volumn 55, Issue 82-83, 2008, Pages 448-452

  Hu, Rey Heng ^a   Lee, Po Huang ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Bioequivalence study; Esophageal variceal hemorrhage; Glypressin; Haemopressin; Terlipressin

Indexed keywords

HAEMOPRESSIN; TERLIPRESSIN; VASOPRESSIN DERIVATIVE;

ABDOMINAL PAIN; ADULT; ARTICLE; BLOOD TRANSFUSION; BRADYCARDIA; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DEMOGRAPHY; DRUG EFFICACY; DRUG SAFETY; ESOPHAGUS VARICES BLEEDING; FEMALE; HEADACHE; HEART ARRHYTHMIA; HUMAN; HYPERTENSION; HYPONATREMIA; LIVER CIRRHOSIS; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THORAX PAIN;

ACUTE DISEASE; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMOGLOBINS; HUMANS; LYSINE VASOPRESSIN; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; VASOCONSTRICTOR AGENTS;

EID: 44349138799     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Graham DY, Smith JL: The course of patients after variceal hemorrhage. Gastroenterology 1981; 80:800-809.
2. Christensen E, Fauerholdt L, Schlichting P, Juhl E, Poulsen H, Tygstrup N: Aspects of the natural history of gastrointestinal bleeding in cirrhosis and the effect of prednisolone. Gastroenterology 1981; 81:944-952.
3. McCormick PA, O'Keefe C: Improving prognosis following a first variceal hemorrhage over four decades. Gut 2001; 49:682-685.
4. Chalasani N, Kahi C, Francois F, et al: Improved patient survival after acute variceal bleeding: a multicenter, cohort study. Am J Gastroenterol 2003; 98:653-659.
5. Carbonell N, Pauwels A, Serfaty L, Fourdan O, George L, Poupon R: Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology 2004; 40:652-659.
6. Inannou GN, Doust J, Rockey DC: Systemic review: terlipressin in acute esophageal variceal hemorrhage. Aliment Pharmacol Ther 2003; 17:53-64.
7. Freeman JG, Cobden I, Lishman AM, Record CO: Controlled trial of terlipressin (Glypressin) versus vasopressin in the early treatment of esophageal varices. Lancet 1982; ii:66-68.
8. Levacher S, Letoumelin P, Pateron D, Blaise M, Lapandry C, Pourriat JL: Early administration of terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients. Lancet 1995; 346:865-868.
9. Banares R, Albillos A, Rincon D, et al: Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta-analysis. Hepatology 2002; 35:609-615.
10. de Franchis R: Updating Consensus in Portal Hypertension: Report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 2000; 33: 846-852.
11. Burroughs AK, Cales P, Kravetz D, et al: Definition of key events - last attempt? In: de Franchis R (Ed.). Portal Hypertension IV. Proceedings of the fourth Baveno international consensus workshop on methodology of diagnosis and treatment. Oxford: Blackwell Publishing Ltd, 2006; pp. 11-39.
12. Haemopressin® Approval number in Germany: 6278136295.00.00.In German Regulatory Authority BfArm, July 2006.
13. Fort E, Sautereau D, Silvain C, Ingrand P, Pillegrand B, Beauchand MA: Randomized trial of terlipressin plus nitroglycerin vs. balloon tamponade in the control acute variceal hemorrhage. Hepatology 1990; 11:678-681.
14. Walker S, Kreichchgauer HP, Bode JH: Terlipressin vs. somatostain in bleeding esophageal varices: a controlled, double-blind study. Hepatology 1992; 15:1023-1030.
15. Feu F, Ruiz-del-Arbol L, Banares R, Plansa R, Bosch J, and members of the Variceal Bleeding Study Group: Double-blind randomized trial comparing terlipressin and somatostatin for acute variceal hemorrhage. Gastroenterology 1996; 111:1291-1299.
16. de Franchis R: Developing consensus in portal hypertension. (Baveno II) J Hepatol 1996; 25:390-394.
17. Fergusson D, Aaron SD, Guyatt G, Hebert P: Post-randomization exclusions: the intention to treat principle and excluding patients from analysis. BMJ 2002; 325:652-654.
18. D'Amico G, Pagliaro L, Bosch J: The treatment of portal hypertension: a meta-analytic review. Hepatology 1995; 22:332-354.
19. Walker S, Stiehl A, Raedsch R, Kommerell B: Terlipressin in bleeding esophageal varices: a placebo-controlled, double-blind study. Hepatology 1984; 6:112-115.
20. D'Amico G, Traina M, Vizzini G, et al: Terlipressin or vasopressin plus transdermal nitroglycerin in a treatment strategy for digestive bleeding in cirrhosis. J Hepatol 1994; 20:206-212.
21. Soderlund C, Magnusson I, Torngren S, Lundell L: Terlipressin (triglycyl-lysine vasopressin) controls acute bleeding esophageal varices. Scand J Gastroenterol 1990; 25:622-630.
22. Escorsell A, Ruiz-del-Arbol L, Panas R, et al: Multicenter randomized controlled trial of terlipressin versus sclerotherapy in the treatment of acute variceal bleeding: the TEST study. Hepatology 2000; 32:471-476.
23. Avgerinos A, Nevens F, Raptis S, Fevery J, and the ABOVE Study Group: Early administration of somatostatin and efficacy of sclerotherapy in acute esophageal variceal bleeds: the European Acute Bleeding Esophageal Variceal Episodes (ABOVE) randomized trial. Lancet 1997; 350:1495-1499.
24. Cales P, Masliah C, Bernard B, et al: Early administration of vapreotide for variceal bleeding in patients with cirrhosis. N Engl J Med 2001; 334:23-28.
25. D'Amico G, Pietrosi G, Tarantino I, Pagliago L: Emergency sclerotherapy versus vasoactive drugs for variceal bleeding in cirrhosis: a Cochrane meta-analysis. Gastroenterology 2003; 124:1277-1291.
26. Laine, Cook D: Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding. A meta-analysis. Ann Intern Med 1995; 123:280-287.
27. Ng WD, Chan YT, HO KK, Kong CK: Injection sclerotherapy for bleeding esophageal varices in cirrhotic patients with hepatocellular carcinoma. Gastrointest Endosc 1989; 35:69-70.